Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paulina Kwaśnik"'
Autor:
Paulina Kwaśnik, Joanna Zaleska, Dorota Link-Lenczowska, Magdalena Zawada, Hubert Wysogląd, Bogdan Ochrem, Grażyna Bober, Ewa Wasilewska, Iwona Hus, Monika Szarejko, Witold Prejzner, Olga Grzybowska-Izydorczyk, Agnieszka Klonowska-Szymczyk, Ewa Mędraś, Michał Kiełbus, Tomasz Sacha, Krzysztof Giannopoulos
Publikováno v:
Cells, Vol 13, Iss 8, p 723 (2024)
Treatment-free remission (TFR) is achieved in approximately half of chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors. The mechanisms responsible for TFR maintenance remain elusive. This study aimed to identify immune ma
Externí odkaz:
https://doaj.org/article/c7e72887b430405ca12d1be455f84335
Publikováno v:
Medycyna Ogólna i Nauki o Zdrowiu, Vol 26, Iss 1, Pp 8-16 (2020)
Despite the progress that has been made in oncology in recent years, the increasing number of cases of cancer forces the search for new, more effective, and above all, safer therapeutic strategies. Immunotherapy, which is based on the mobilization an
Externí odkaz:
https://doaj.org/article/a4d3e3d3d85a4ea18b58fa23f4bab918
Publikováno v:
Medycyna Ogólna i Nauki o Zdrowiu, Vol 26, Iss 1, Pp 8-16 (2020)
Despite the progress that has been made in oncology in recent years, the increasing number of cases of cancer forces the search for new, more effective, and above all, safer therapeutic strategies. Immunotherapy, which is based on the mobilization an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::722030820ae33828159f0bee21e4a686
http://www.journalssystem.com/monz/Mozliwosci-wykorzystania-komorek-NK-w-immunoterapii-nowotworow,116591,0,2.html
http://www.journalssystem.com/monz/Mozliwosci-wykorzystania-komorek-NK-w-immunoterapii-nowotworow,116591,0,2.html
Publikováno v:
Annals of agricultural and environmental medicine : AAEM. 28(2)
Introduction Due to the fact that lymphocytes NK (natural killer cells) are the first line of defence of the body against cancer, one of the goals of modern immunotherapy is the enhancement of their natural activities for the effective recognition, d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4742c2891c15cf1f05eb661bdcc15df3
https://pubmed.ncbi.nlm.nih.gov/34184513
https://pubmed.ncbi.nlm.nih.gov/34184513
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 697, p 697 (2021)
Journal of Personalized Medicine, Vol 11, Iss 697, p 697 (2021)
Tyrosine kinases inhibitors (TKIs) revolutionized chronic myeloid leukemia (CML) treatment for many years, prolonging patients’ life expectancy to be comparable to age-matched healthy individuals. According to the latest the European LeukemiaNet (E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80057d9efce97478bc8e9dc5b8b985d7
https://doi.org/10.3390/jpm11080697
https://doi.org/10.3390/jpm11080697